cisatracurium besylate (Jiangsu Hengrui Medicine Co., Ltd.)


Welcome to the PulseAid listing for the cisatracurium besylate drug offered from Jiangsu Hengrui Medicine Co., Ltd.. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Jiangsu Hengrui Medicine Co., Ltd.
NON-PROPRIETARY NAME: cisatracurium besylate
SUBSTANCE NAME: CISATRACURIUM BESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-27
END MARKETING DATE: 0000-00-00


cisatracurium besylate HUMAN PRESCRIPTION DRUG Details:

Item Descriptioncisatracurium besylate from Jiangsu Hengrui Medicine Co., Ltd.
LABELER NAME: Jiangsu Hengrui Medicine Co., Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2017-01-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57884-3061_5a426ee0-2f8a-7e1b-e053-2991aa0a0b54
PRODUCT NDC: 57884-3061
APPLICATION NUMBER: ANDA204960

Other CISATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Nimbex
Fresenius Kabi USA, LLCCisatracurium
Jiangsu Hengrui Medicine Co., Ltd.cisatracurium besylate
Sandoz Inccisatracurium besylate